|Bid||11.36 x 2200|
|Ask||19.28 x 1400|
|Day's range||11.19 - 12.08|
|52-week range||4.61 - 49.47|
|Beta (5Y monthly)||2.29|
|PE ratio (TTM)||N/A|
|Earnings date||05 Oct 2022 - 10 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.06|
GRAND RAPIDS, Mich., July 20, 2022--Priority Health, a nationally recognized nonprofit health plan, announced today the launch of PriorityGPS™, an integrated health navigation and advocacy solution. PriorityGPS will be delivered through a strategic partnership with Accolade (Nasdaq: ACCD), a Personalized Healthcare service, and is available for self-funded (ASO), large employers.
Good day, and thank you for standing by, and welcome to the Accolade first quarter 2023 earnings results conference call. With me on the call today are our chief executive officer, Rajeev Singh; and our chief financial officer, Steve Barnes. Shantanu Nundy, our chief medical officer, will join for the question-and-answer portion of the call.
Accolade (ACCD) delivered earnings and revenue surprises of 45.21% and 3.80%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?